BackgroundIn response to the persistent TB challenge, the National Tuberculosis Elimination Programme (NTEP) of India, formerly known as the Revised National Tuberculosis Control Programme (RNTCP), set a strategic goal to eliminate the nation's TB burden by 2025, five years ahead of the Sustainable Development Goals. In recognition of this challenge, the Indian Government launched the Sub-national Certification initiative in 2021, fostering competition among states and districts to attain TB-free status and offering recognition and incentives to the best-performing entities. Leveraging verification methods such as TB scores, treatment data, and community-level incidence estimation, this study seeks to provide a comprehensive view of the landscape. Materials & methodsThe study targeted healthcare providers encompassing doctors and chemists employed in both public and private sectors. A non-probability sampling technique, specifically, the convenient sampling method, was utilized. Two Nominal Group Technique (NGT) sessions were conducted. The first NGT comprised 8 healthcare providers, while the second NGT included 10 healthcare providers, while 14 participants were interviewed for KII. ResultsUtilizing the nominal group technique, the following results were derived: approximately 20 % of patients opt for treatment in the private sector, and pharmacies notifying TB cases comprise around 70 % of the cases. Additionally, most participants concurred that there has been a reduction in TB cases over recent years. ConclusionStudy's findings shed light on healthcare providers' perspectives on various facets of TB control, including incidence trends, patient preferences, drug choices, and compliance.